Arabio inks partnership deal with AbbVie

April 13, 2014 1:15 am

Saudi-based Arab Company for Pharmaceutical Products (Arabio) has signed an agreement with US-based research-based pharmaceuticals firm, AbbVie, to manufacture arthritis drug, Humira, and other medicines in the kingdom, Arab News ahs reported. The deal is a “realisation of [the] Saudi government to develop biological manufacturing capabilities in Saudi Arabia,” said general manager and CEO of Arabio, Majed Saeed Bahatheq.